Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More
- PMID: 33320222
- DOI: 10.1001/jama.2020.24075
Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More
Similar articles
-
COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.Ann Intern Med. 2021 Mar;174(3):413-414. doi: 10.7326/M21-0331. Epub 2021 Jan 25. Ann Intern Med. 2021. PMID: 33492990 Free PMC article.
-
A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.JAMA. 2021 Jan 5;325(1):17-18. doi: 10.1001/jama.2020.23848. JAMA. 2021. PMID: 33399836 No abstract available.
-
ASHP principles for COVID-19 vaccine distribution, allocation, and mass immunization.Am J Health Syst Pharm. 2020 Dec 4;77(24):2112-2113. doi: 10.1093/ajhp/zxaa311. Am J Health Syst Pharm. 2020. PMID: 32871003 Free PMC article.
-
SARS-CoV-2 Vaccines.JAMA. 2021 Apr 6;325(13):1318-1320. doi: 10.1001/jama.2021.3199. JAMA. 2021. PMID: 33635317 Review. No abstract available.
-
[Immunity against SARS-CoV-2: walking to the vaccination].Rev Esp Quimioter. 2020 Dec;33(6):392-398. doi: 10.37201/req/086.2020. Epub 2020 Sep 11. Rev Esp Quimioter. 2020. PMID: 32935536 Free PMC article. Review. Spanish.
Cited by
-
SARS-CoV-2 re-infection risk in Austria.Eur J Clin Invest. 2021 Apr;51(4):e13520. doi: 10.1111/eci.13520. Epub 2021 Feb 21. Eur J Clin Invest. 2021. PMID: 33583018 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical